Companies: 10,795·Total market cap: $144.5T

LakeShore Biopharma Co., Ltd

LakeShore Biopharma Co., Ltd

LSBNASDAQHealthcare

$0.63

+$0.00(+0.00%)

Market Cap$25840359

P/E Ratio—

52W High$8.6

52W Low$0.574

Avg Volume348K

Open$0.79

Beta0.57

LakeShore Biopharma Co., Ltd (LSB) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

LSB · net income · updated Jun 9, 2026

Core profitability metrics

LSB · net income · margin · TTM · CAGR

Net income was −$100.0M for FY2025 (fiscal year ending 2025-03-31), up 76.9% year-over-year. Net profit margin was -16.3%.

FY2025 Net Income−$100.0M▲ +76.9% YoY

Trailing 12M (TTM)−$433.7Mtrailing 4 quarters sum

Net Profit Margin-16.3%−$100.0M ÷ $615.0M

YoY Change+76.9%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · LSB net income history · LSB profit margin

Annual net income data

LSB · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$100.0M▲ +76.9%-16.3%$615.0M

FY2024Loss−$433.5M▼ 198.0%-75.6%$573.4M

FY2023Loss−$145.5M▲ +38.5%-21.2%$687.2M

FY2022Loss−$236.7M▼ 23.4%-47.1%$502.9M

FY2021Loss−$191.8M—-74.6%$257.0M

Net income vs peers (Healthcare)

LSB vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

LakeShore Biopharma Co., LtdYOU

LSB

−$100.0M+76.9%-16.3%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

LakeShore Biopharma Co., Ltd (LSB) reported net income of −$100.0M for FY2025 (fiscal year ending 2025-03-31), up 76.9% year-over-year. The net profit margin was -16.3% — meaning the company kept $-0.16 of every dollar of revenue as profit.

LakeShore Biopharma Co., Ltd has not yet achieved annual profitability based on available data (5 fiscal years). The company has reported net losses across all available periods.

LakeShore Biopharma Co., Ltd's net profit margin was -16.3% for FY2025, based on the latest annual results.

Investors sometimes search for "LakeShore Biopharma Co., Ltd net worth" — the company's market capitalization is a separate figure from LSB net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

LSB net income · 4 questions

LakeShore Biopharma Co., Ltd is not currently profitable on an annual basis. The company reported a net loss of $100.0M for FY2025.

is LSB profitabledoes LSB make a profitLSB profitabilityLSB profitable company

▸ Source: FMP /income-statement · GAAP · LakeShore Biopharma Co., Ltd · LakeShore Biopharma Co., Ltd SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026